 |
Journal articles
Interferon in chronic myeloid leukaemia: past and future.
Abstract : Imatinib has revolutionized the therapy of chronic myeloid leukaemia. However the complete eradication of leukaemic stem cells is still a matter of discussion. Interferon (IFN) has been used in the past with success. However the proportion of patients who achieved sustained complete cytogenetic response was small. Recently, in addition to its direct antineoplastic effect and immunomodulatory activity, IFN has been shown to stimulate the quiescent leukaemic stem cells. Thus there is now a rational for combining Imatinib and IFN. Large prospective phase III trials are in good progress to demonstrate in humans the usefullness of a combination therapy using Imatinib and IFN.
Cited literature [74 references]
https://www.hal.inserm.fr/inserm-00441364
Contributor : Francois Guilhot-Gaudeffroy <>
Submitted on : Tuesday, December 15, 2009 - 6:42:17 PM
Last modification on : Sunday, October 25, 2020 - 7:07:43 AM
Long-term archiving on: : Saturday, November 26, 2016 - 4:48:30 PM
Contributor : Francois Guilhot-Gaudeffroy <>
Submitted on : Tuesday, December 15, 2009 - 6:42:17 PM
Last modification on : Sunday, October 25, 2020 - 7:07:43 AM
Long-term archiving on: : Saturday, November 26, 2016 - 4:48:30 PM